首页> 美国卫生研究院文献>World Journal of Hepatology >Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases
【2h】

Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases

机译:生物工程化的功能化人性化肝脏:一种新兴的支持方式弥合了器官移植治疗晚期肝病的差距

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

End stage liver diseases (ESLD) represent a major, neglected global public health crisis which requires an urgent action towards finding a proper cure. Orthotropic liver transplantation has been the only definitive treatment modality for ESLD. However, shortage of donor organs, timely unavailability, post-surgery related complications and financial burden on the patients limits the number of patients receiving the transplants. Since last two decades cell-based therapies have revolutionized the field of organ/tissue regeneration. However providing an alternative organ source to address the donor liver shortage still poses potential challenges. The developments made in this direction provide useful futuristic approaches, which could be translated into pre-clinical and clinical settings targeting appropriate applications in specific disease conditions. Earlier studies have demonstrated the applicability of this particular approach to generate functional organ in rodent system by connecting them with portal and hepatic circulatory networks. However, such strategy requires very high level of surgical expertise and also poses the technical and financial questions towards its future applicability. Hence, alternative sites for generating secondary organs are being tested in several types of disease conditions. Among different sites, omentum has been proved to be more appropriate site for implanting several kinds of functional tissue constructs without eliciting much immunological response. Hence, omentum may be considered as better site for transplanting humanized bioengineered ex vivo generated livers, thereby creating a secondary organ at intra-omental site. However, the expertise for generating such bioengineered organs are limited and only very few centres are involved for investigating the potential use of such implants in clinical practice due to gap between the clinical transplant surgeons and basic scientists working on the concept evolution. Herein we discuss the recent advances and challenges to create functional secondary organs through intra-omental transplantation of ex vivo generated bioengineered humanized livers and their further application in the management of ESLD as a supportive bridge for organ transplantation.
机译:晚期肝病(ESLD)代表着一个重大的,被忽视的全球性公共卫生危机,需要采取紧急行动以找到适当的治疗方法。正交各向异性肝移植一直是ESLD唯一确定的治疗方式。但是,供体器官短缺,无法及时使用,与手术有关的并发症以及患者的经济负担限制了接受移植的患者数量。自最近二十年来,基于细胞的疗法彻底改变了器官/组织再生领域。然而,提供替代器官来源以解决供体肝短缺仍然构成潜在挑战。在这个方向上的发展提供了有用的未来方法,可以将其转化为针对特定疾病条件下的适当应用的临床前和临床环境。较早的研究表明,这种特定方法通过将它们与门和肝循环网络连接而在啮齿动物系统中产生功能器官的适用性。然而,这样的策略需要非常高水平的外科专业知识,并且也对其未来的适用性提出了技术和经济上的问题。因此,正在几种类型的疾病中测试产生次生器官的替代位点。在不同部位之间,网膜已被证明是更合适的部位,可植入多种功能性组织构建体,而不会引起很多免疫反应。因此,网膜可以被认为是移植人源化生物工程离体产生的肝脏的较好部位,从而在网膜内部位形成次级器官。然而,由于临床移植外科医生与从事概念演变的基础科学家之间存在差距,因此产生这种生物工程器官的专业知识是有限的,只有很少的研究中心参与调查这种植入物在临床实践中的潜在用途。本文中,我们讨论了通过网膜内移植离体产生的生物工程化人源化肝脏来创建功能性次级器官的最新进展和挑战,以及它们在ESLD的管理中作为器官移植的支持桥梁的进一步应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号